<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="5dd282f2-9ea2-4c87-a379-a5520ea27cdb"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neuromuscular Neurology Consultation — Wilma Mankiller</title>
  <effectiveTime value="20260323120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="b1031998-5765-4668-ae57-201bbb73cf35"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="4fe565cc-0bef-43be-ade3-fd9e41828ea2" extension="HR-ML052-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-52-4183"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Wilma</given><family>Mankiller</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19911118"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260323120000-0500"/>
    <assignedAuthor><id root="d7d7f3a8-bf44-4b2a-a640-435799198fe4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Delaney</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260323120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="d7d7f3a8-bf44-4b2a-a640-435799198fe4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Delaney</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="ae33d7f0-b9a9-4913-b5e3-3447427bcd6a"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="d7d7f3a8-bf44-4b2a-a640-435799198fe4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Delaney</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="c75e5612-5828-46ac-a004-5efb4b4a1664"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review with the neuromuscular neurology consultation the same day: antibody, nerve stimulation, chest CT and kidney ultrasound results, the diagnosis, and the treatment plan</originalText></code>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="d7d7f3a8-bf44-4b2a-a640-435799198fe4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Marcus</given><family>Okafor-Delaney</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Woman of 34 with six weeks of fluctuating ptosis, diplopia and fatigable weakness of the arms, neck, chewing and voice, while recovering from a severe car crash last year: suspected generalized myasthenia gravis. Please confirm the diagnosis and advise on treatment, thymectomy and safety. [S]</paragraph><paragraph>Urgency: Urgent, within two weeks. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Do you agree with the diagnosis, and are MuSK antibodies or single-fiber EMG needed?</item><item>What pyridostigmine dose, and how should immunotherapy begin?</item><item>Which steroid-sparing agent suits a woman of 34 with polycystic kidney disease, and what screening is needed first?</item><item>Should she have a thymectomy, and when, so soon after major trauma?</item><item>Is there a place now for newer targeted therapies such as efgartigimod or eculizumab?</item><item>What should she and primary care watch for: crisis warning signs, medicines to avoid, and any kidney considerations?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Mankiller is seen at the request of Dr. Hawkfeather-Lindqvist for six weeks of drooping eyelids, double vision by evening, tiring of the arms when brushing her hair, a tired jaw while eating, and a nasal voice after long conversations. Pyridostigmine 30 mg three times daily has helped her eyelids for a few hours after each dose, with mild cramps. She has had no breathlessness, choking or weak cough. She is recovering from a head-on car crash last year with fractures of both legs, ribs and face and many operations, and walks with a cane on rough ground. She has hereditary polycystic kidney disease with normal kidney function. She works for the Cherokee Nation and lives in rural Adair County. She wants to understand each treatment before agreeing to it, and to have blood tests near home. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Wilma Pearl Mankiller was born on November 18, 1945, in Tahlequah, Oklahoma, the capital of the Cherokee Nation, the sixth of eleven children; her father was a full-blood Cherokee. A Cherokee Nation release gave her birthplace as the W.W. Hastings Indian Hospital in Tahlequah; the Oklahoma Hall of Fame says she was born at Rock Mountain in Adair County. [D]</item><item>As a child she moved with her family from Mankiller Flats in Adair County to San Francisco under the Bureau of Indian Affairs relocation program (1956 or 1957 by different accounts); she later described the move as her own little Trail of Tears. [D]</item><item>The occupation of Alcatraz Island in 1969 and her work with American Indian communities in California in the 1970s set the course of her activism. [D]</item><item>She returned to eastern Oklahoma with her two daughters in the later 1970s (1976 or 1977 by different accounts), worked for the Cherokee Nation, and lived on her grandfather&apos;s allotment, Mankiller Flats, in Adair County. [D]</item><item>In 1979 she was nearly killed in a head-on car crash on a curve, in which the driver of the other car, one of her best friends, died. She needed about 17 operations; accounts say her leg was barely saved from amputation and that she was told she might never walk again. The Oklahoma Hall of Fame dates the crash to 1978 and describes shattered legs, broken ribs and a crushed face. [D]</item><item>Her recovery was made harder by the emotional trauma of her friend&apos;s death in the crash. [D]</item></list><paragraph>8 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="34f92ef3-a565-4ed8-adde-491177a70b50"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="3c1fbb93-721a-4c30-871e-4554018caad3"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eating</td><td>One tablet three times daily</td><td>Oral route</td><td>2026-03-09 to 2026-03-23</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before meals</td><td>One tablet four times daily while awake</td><td>Oral route</td><td>2026-03-23 to 2026-10-12</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mg</td><td>Once each morning; dose as directed</td><td>Oral route</td><td>2026-03-23 to 2026-07-13</td><td>completed</td><td>S</td></tr><tr ID="medication-7"><td>Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with food</td><td>One tablet daily with food</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr><tr ID="medication-10"><td>Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg pain</td><td>One or two tablets up to three times daily as needed</td><td>Oral route</td><td>2025-09-15</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="3de083a1-dfb1-405d-9475-06b000ffe2aa"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260309"/><high value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="903841" codeSystem="2.16.840.1.113883.6.88" displayName="pyridostigmine bromide 30 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e6236247-eced-46e7-8b55-d5e15baa4463"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="H53.2" codeSystem="2.16.840.1.113883.6.90" displayName="Diplopia"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ab530837-60d3-4bd5-a729-c5908aeddbc1"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/><high value="20261012"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="903857" codeSystem="2.16.840.1.113883.6.88" displayName="pyridostigmine bromide 60 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="1fb3a7a5-246f-40e1-81cc-368ecbec217d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="597b317a-091d-4595-bd73-724f23f27282"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/><high value="20260713"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198145" codeSystem="2.16.840.1.113883.6.88" displayName="prednisone 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8cec7c75-ec08-4910-a6cc-33dcca94c635"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="cc71ee74-e60c-4397-9735-95b63184338b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="740250ff-3749-4b1e-b298-8776c7ed1b91"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="282465" codeSystem="2.16.840.1.113883.6.88" displayName="calcium carbonate 1250 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3e66adb6-33c2-49d0-a865-3f0166b964e2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2917a9dc-52b1-4296-9eb1-30a8a76083bb"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199362" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.025 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="88013abc-f5dc-43ce-a578-0852cc8fb49d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b0c5b0a0-09c0-4a33-bdbc-9a051328f5a8"/>
      <text><reference value="#medication-10"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250915"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="9b03ca49-c7a0-4883-a355-0f9c4ba6de01"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z87.81" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of (healed) traumatic fracture"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspected</td><td>resolved</td><td>confirmed</td>
    <td>H53.2</td><td>S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.</td>
  </tr>
  <tr ID="problem-2">
    <td>Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1980</td><td>active</td><td>confirmed</td>
    <td>G70.00</td><td>S — Synthetic antibody level, electrodiagnosis, class and treatment; the diagnosis less than a year after the crash, and recovery with Cherokee medicine people, surgery and drug therapy, are documented (D).</td>
  </tr>
  <tr ID="problem-3">
    <td>Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be staged</td><td>active</td><td>confirmed</td>
    <td>Q61.2</td><td>S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.</td>
  </tr>
  <tr ID="problem-4">
    <td>Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough ground</td><td>active</td><td>confirmed</td>
    <td>Z87.81</td><td>S — The crash, the operations and the injuries are documented (D); the current function is synthetic.</td>
  </tr>
  <tr ID="problem-5">
    <td>Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infection</td><td>active</td><td>confirmed</td>
    <td>Z79.52</td><td>S — Synthetic treatment plan.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7e29389b-b6ed-425e-a761-f2b23ca52e1e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="89c73303-da81-4fc6-8064-5e3fd4f50a54"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="H53.2" codeSystem="2.16.840.1.113883.6.90" displayName="Diplopia"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a8297c83-5e94-4a36-af8a-412993fd2a61"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="1938fb8e-d32e-40cd-bc91-a058f521bfde"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="bafd5325-a8bd-4cc2-a943-c748c49baf92"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="64aa827c-b151-4a12-8e3b-bae341242107"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Q61.2" codeSystem="2.16.840.1.113883.6.90" displayName="Polycystic kidney, adult type"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="4fe0389e-703d-4cd8-94b7-22206b8a7800"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="51d8b68e-08f9-4a8f-b716-239d557ae378"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Z87.81" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of (healed) traumatic fracture"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c9cc67b0-e2a8-434e-9461-579e7089c524"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b3e7fb0a-d3fe-48a8-ab81-d09227eedd7c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-03-23; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>Eyes</td><td>Left ptosis after 40 seconds of upgaze; diplopia on sustained right gaze; pupils normal</td></tr><tr><td>Bulbar</td><td>Speech becomes nasal after counting to 40; jaw closure strong at rest</td></tr><tr><td>Neurological</td><td>Neck flexion 4 of 5; deltoids fatigue after 45 seconds of arm abduction; reflexes and sensation normal</td></tr><tr><td>Respiratory</td><td>Single-breath count to 30; FVC 3.25 L; negative inspiratory force -68 cm H2O</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-19"><td>2026-03-23</td><td>Acetylcholine receptor binding Ab [Moles/volume] in Serum</td><td>6.8</td><td>nmol/L</td><td>0.02 nmol/L or less is negative</td><td>High</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-03-23</td><td>Forced vital capacity [Volume] Respiratory system</td><td>3.25</td><td>L</td><td>Lower limit of normal about 2.9 L for her age, sex and height</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-21"><td>2026-03-23</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="ef1127d1-fe94-4acc-b997-c82f5d8e1729"/>
      <code code="11034-6" codeSystem="2.16.840.1.113883.6.1" displayName="Acetylcholine receptor binding Ab [Moles/volume] in Serum"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="21daf352-da97-4ab8-ad77-559bf0a277a5"/>
          <code code="11034-6" codeSystem="2.16.840.1.113883.6.1" displayName="Acetylcholine receptor binding Ab [Moles/volume] in Serum"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="6.8" unit="nmol/L"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>0.02 nmol/L or less is negative</text>
              <value xsi:type="IVL_PQ"><high value="0.02" unit="nmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="11bbd9bf-6241-4421-b5b6-9c9ddff00081"/>
      <code code="19870-5" codeSystem="2.16.840.1.113883.6.1" displayName="Forced vital capacity [Volume] Respiratory system"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="3e02dbca-7676-458f-8167-523356af4063"/>
          <code code="19870-5" codeSystem="2.16.840.1.113883.6.1" displayName="Forced vital capacity [Volume] Respiratory system"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="3.25" unit="L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Lower limit of normal about 2.9 L for her age, sex and height</text>
              <value xsi:type="IVL_PQ"><low value="2.9" unit="L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3a927154-46aa-4dc1-aaea-4e8d3f782703"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="56d47256-a579-4808-803b-f06291c27370"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Generalized myasthenia gravis, AChR antibody positive, MGFA class IIa, MG-ADL 7, without thymoma (G70.00). The diagnosis is confirmed by a positive antibody and a reproducible decrement on nerve stimulation; MuSK antibodies and single-fiber EMG are not needed. The weakness is mild to moderate and mainly ocular and limb, with mild bulbar involvement. Breathing measurements are normal, and there is no sign of impending crisis. [S]</item><item>Immunotherapy (Z79.52). Pyridostigmine alone is unlikely to control generalized disease. Prednisone is the first immunotherapy; starting at 10 mg and raising it by 10 mg a week to 40 mg lowers the risk of the early worsening that high starting doses can cause. A steroid-sparing agent is advised from the start because she is likely to need treatment for years. Azathioprine suits a woman of childbearing age better than mycophenolate, which must be avoided in pregnancy; it needs TPMT activity first, hepatitis B and tuberculosis screening, and regular blood counts and liver tests. Polycystic kidney disease with normal function does not change these doses. Pneumococcal and recombinant zoster vaccines should be given before immunosuppression, and live vaccines avoided. [S]</item><item>Thymectomy. In non-thymomatous AChR antibody-positive generalized MG between 18 and 50, thymectomy early in the disease improves outcomes and lowers immunotherapy needs (MGTX). It is elective and should be done once she is stable. Her healed rib fractures do not prevent a robotic approach from the right; she should see thoracic surgery in about four weeks, with surgery once prednisone has taken effect, about two to three months from now. [S]</item><item>Newer targeted therapies. Efgartigimod, an FcRn blocker, and the complement inhibitors eculizumab and ravulizumab work well in AChR antibody-positive generalized MG, but the guidance places complement inhibitors after other immunotherapies have failed, and her disease is not refractory. They are kept in reserve. A complement inhibitor would need meningococcal vaccination first. [S]</item><item>Safety, medicines to avoid and kidney considerations (Q61.2). Fluoroquinolones, aminoglycosides, macrolides, telithromycin, magnesium by vein, beta-blockers and neuromuscular blocking drugs can worsen MG; statins and iodinated contrast need caution. Her kidney function is normal, so drug doses and contrast are not limited by it, but NSAIDs should be avoided for her kidneys and a beta-blocker should not be chosen if her blood pressure ever needs treatment. [S]</item></list><paragraph>Data reviewed: Acetylcholine receptor binding antibodies 6.8 nmol/L (positive), drawn at the first visit; CT of the chest with contrast five days ago (residual thymic tissue for age, no thymoma, healed right rib fractures); kidney ultrasound five days ago (enlarged polycystic kidneys, height-adjusted total kidney volume 364 mL/m, Mayo Imaging Class 1B; small liver cysts); first-visit blood count, chemistry, TSH 1.9 mIU/L, hemoglobin A1c, urine albumin, FVC and negative inspiratory force; and repetitive nerve stimulation done today (3 Hz: 22 percent decrement in the nasalis, 18 percent in the trapezius, with partial repair after exercise). [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Pyridostigmine 60 mg four times daily while awake, 30 to 45 minutes before meals. [S]</item><item>Prednisone 10 mg each morning, raised by 10 mg each week to 40 mg, held until after thymectomy, then tapered by 5 mg every two to three weeks toward 7.5 mg or less. [S]</item><item>Azathioprine once TPMT activity is normal and hepatitis B and tuberculosis screening are negative: 50 mg daily, 100 mg after two weeks, then about 2 to 3 mg/kg (150 mg); blood count and liver tests every one to two weeks for two months, then every three months. [S]</item><item>Calcium and vitamin D, DXA within the first months, and trimethoprim-sulfamethoxazole three times a week while prednisone is 20 mg or more with azathioprine. [S]</item><item>PCV20 and recombinant zoster vaccine today, before immunosuppression; inactivated vaccines only from now on. [S]</item><item>Thoracic surgery assessment in about four weeks for robotic extended thymectomy once she is stable. [S]</item><item>Efgartigimod or a complement inhibitor only if she does not respond to, or cannot tolerate, standard immunotherapy. [S]</item><item>A wallet card listing the medicines to avoid; same-day emergency care for breathlessness lying flat, a weak cough, choking or slurred speech, with FVC and negative inspiratory force measured at every visit while she is weak. [S]</item><item>Discuss any planned pregnancy with neuromuscular neurology first. [S]</item><item>Discussed with Dr. Hawkfeather-Lindqvist today. The plan was explained to Ms. Mankiller step by step, with time for her questions, and she agreed to it. Blood tests will be drawn at a Cherokee Nation Health Services clinic near her home where possible, with results sent to both clinics. She will decide whether and how her own Cherokee medicine is part of her care, and will tell us of any plant medicine so that interactions can be checked. [S]</item><item>Follow-up: Nurse telephone call in one week as prednisone rises. Thoracic surgery assessment in about four weeks. Neuromuscular neurology review after thymectomy and every three months. Primary care follows her strength, breathing, glucocorticoid and azathioprine safety, and her kidney care at each visit. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
